Biyik-Sit, R.; Kruer, T.; Dougherty, S.; Bradley, J.A.; Wilkey, D.W.; Merchant, M.L.; Trent, J.O.; Clem, B.F.
Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells. Cancers 2021, 13, 3938.
https://doi.org/10.3390/cancers13163938
AMA Style
Biyik-Sit R, Kruer T, Dougherty S, Bradley JA, Wilkey DW, Merchant ML, Trent JO, Clem BF.
Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells. Cancers. 2021; 13(16):3938.
https://doi.org/10.3390/cancers13163938
Chicago/Turabian Style
Biyik-Sit, Rumeysa, Traci Kruer, Susan Dougherty, James A. Bradley, Daniel W. Wilkey, Michael L. Merchant, John O. Trent, and Brian F. Clem.
2021. "Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells" Cancers 13, no. 16: 3938.
https://doi.org/10.3390/cancers13163938
APA Style
Biyik-Sit, R., Kruer, T., Dougherty, S., Bradley, J. A., Wilkey, D. W., Merchant, M. L., Trent, J. O., & Clem, B. F.
(2021). Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells. Cancers, 13(16), 3938.
https://doi.org/10.3390/cancers13163938